-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Ardent Health, Lowers Price Target to $13

Benzinga·03/10/2026 13:19:31
Listen to the news
RBC Capital analyst Ben Hendrix maintains Ardent Health (NYSE:ARDT) with a Outperform and lowers the price target from $14 to $13.